Literature DB >> 25255911

Medical Director Responsibilities to the ESRD Network.

Peter B DeOreo1, Jay B Wish2.   

Abstract

The 18 regional ESRD Networks are established in legislation and contract with the Centers for Medicare and Medicaid Services to improve the quality and safety of dialysis, maximize patient rehabilitation, encourage collaboration among and between providers toward common quality goals, and improve the reliability and the use of data in pursuit of quality improvement. The Networks are funded by a $0.50 per treatment fee deducted from the reimbursement to dialysis providers, and their deliverables are determined by a statement of work, which is updated in a new contract every 3 years. The Conditions for Coverage require dialysis providers to participate in Network activities, and failure to do so can be the basis for sanctions against the provider. However, the Networks attempt to foster a collegial relationship with dialysis facilities by offering tools, educational activities, and other resources to assist the facilities in meeting the evolving requirements by the Centers for Medicare and Medicaid Services on the basis of national aims and domains for quality improvement in health care that transcend the ESRD program. Because of his/her responsibility for implementing the quality assessment and performance improvement activities in the facility, the medical director has much to gain by actively participating in Network activities, especially those focused on quality, safety, patient grievance, patient engagement, and coordination of care. Membership on Network committees can also foster the professional growth of the medical director through participation in quality improvement activity development and implementation, authorship of articles in peer-reviewed journals, creation of educational tools and presentations, and application of Network-sponsored materials to improve patient outcomes, engagement, and satisfaction in the medical director's facility. The improvement of care of patients on dialysis will be beneficial to the facility in achieving its goals of quality, safety, and financial viability.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  ESRD; chronic dialysis; outcomes

Mesh:

Year:  2014        PMID: 25255911      PMCID: PMC4594070          DOI: 10.2215/CJN.05350514

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  8 in total

Review 1.  Can better understanding and use of treatment center performance feedback improve hemodialysis care? A role for the medical director.

Authors:  Peter B DeOreo; Raynel Wilson; Jay B Wish
Journal:  Semin Dial       Date:  2012-04-12       Impact factor: 3.455

Review 2.  Vascular access for dialysis in the United States: progress, hurdles, controversies, and the future.

Authors:  Jay B Wish
Journal:  Semin Dial       Date:  2010-12-20       Impact factor: 3.455

3.  Medical direction of dialysis--a critical leadership role.

Authors:  Robert A Gutman
Journal:  Semin Dial       Date:  2007 May-Jun       Impact factor: 3.455

4.  Improving outcomes for ESRD patients: shifting the quality paradigm.

Authors:  Allen R Nissenson
Journal:  Clin J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 8.237

5.  What is expected of a medical director in the Centers for Medicare and Medicaid Services Conditions of Coverage?

Authors:  Jay B Wish
Journal:  Blood Purif       Date:  2011-01-10       Impact factor: 2.614

6.  ESRD Networks: past, present, and challenges for the future.

Authors:  Jay B Wish; Klemens B Meyer
Journal:  Clin J Am Soc Nephrol       Date:  2012-09-13       Impact factor: 8.237

7.  Physician visits and 30-day hospital readmissions in patients receiving hemodialysis.

Authors:  Kevin F Erickson; Wolfgang C Winkelmayer; Glenn M Chertow; Jay Bhattacharya
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

8.  Association between repeat hospitalization and early intervention in dialysis patients following hospital discharge.

Authors:  Kevin E Chan; J Michael Lazarus; Rebecca L Wingard; Raymond M Hakim
Journal:  Kidney Int       Date:  2009-06-10       Impact factor: 10.612

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.